A mulit-centre, long term follow-up, open label trial to assess the efficacy and safety of Cpn10 in subjects with rheumatoid arthritis (Protocol number CBIO2008-01).
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs INV 103 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors CBio
- 03 Feb 2011 Status changed from recruiting to discontinued as reported by Australian New Zealand Clinical Trials Registry record.
- 03 Feb 2009 New trial record